Kossel Medtech was successfully selected as a “Unicorn” cultivation enterprise in Suzhou! The concept of “unicorn” was first proposed in 2013 by Aileen Lee, the founder of Cowboy Ventures. Features such as growth and disruptive innovation.
Unicorn enterprises are typical representatives of scientific and technological innovation enterprises. They reflect the development trend of the industry and the competitiveness of the country, lead the vane of new economic development, and are also an important indicator of an enterprise’s innovation ability, innovation vitality and innovation ecology.
Kossel Medtech has a full range of production and R&D capabilities. The research projects involve four major areas: peripheral intervention, coronary intervention, cardiac electrophysiology and OEM . Among them, the vena cava filter in the peripheral intervention field enters the “green channel” of innovative medical devices of the NMPA. The PTCA balloon catheter in the field of coronary intervention has entered the global mainstream market, with sales covering more than 20 countries including China, the United States, Germany, and France.
Kossel Medtech has 93 intellectual property rights, including 31 invention patents. It has obtained 3 Class III medical device registration certificates and 2 Class II registration certificates in China, and 9 certificates from the United States, the European Union, Japan, and South Korea. It is expected to get 3 domestic third-class medical device registration certificates and 2 FDA certificates in 2021.
Kossel Medtech is an innovative and intelligent medical device platform company dedicated to providing clinical system solutions that can benefit more patients.